Quick Notes: Drug Approvals, Device Clearance — March 28, 2024

By PacConAdmin | March 28, 2024 | 0

This edition of Quick Notes reviews Merck’s pulmonary arterial hypertension treatment with Winrevair, a fourth approval for AstraZeneca’s Ultomiris, Akebia approval for Vafseo tablets and another clearance for Neuronetics’ Neurostar device.
Source: Drug Industry Daily

Posted in Uncategorized and tagged

Leave a Comment





This site uses Akismet to reduce spam. Learn how your comment data is processed.